IRVING, Texas, June 17, 2025 – Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the pricing of its initial public offering of 23,529,412 shares of its common stock, at a public offering price of $21.00 per share. In addition, Caris has granted the underwriters a 30-day … Continue reading Caris Life Sciences Announces Pricing of Initial Public Offering